PierianDx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 324

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

  • Investments
  • 1

PierianDx General Information

Description

Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The company's software uses artificial intelligence to automate the process of taking DNA sequencing data through analysis, interpretation and final report, thereby empowering physicians in the laboratory and clinic to effectively diagnose and treat patients with cancer and other complex diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 6 Cityplace Drive
  • Suite 550
  • Creve Coeur, MO 63141
  • United States
+1 (314)
Primary Industry
Decision/Risk Analysis
Parent Company
Corporate Office
  • 6 Cityplace Drive
  • Suite 550
  • Creve Coeur, MO 63141
  • United States
+1 (314)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PierianDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PierianDx‘s full profile, request access.

Request a free trial

PierianDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The comp
Decision/Risk Analysis
Creve Coeur, MO
324 As of 2023

Harderwijk, Netherlands
 

Bangalore, India
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PierianDx Competitors (22)

One of PierianDx’s 22 competitors is Genalice, a Formerly PE-Backed company based in Harderwijk, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genalice Formerly PE-Backed Harderwijk, Netherlands
InterpretOmics Formerly VC-backed Bangalore, India
Fabric Genomics Venture Capital-Backed Oakland, CA
Genoox Private Equity-Backed Palo Alto, CA
Gene By Gene Formerly VC-backed Houston, TX
You’re viewing 5 of 22 competitors. Get the full list »

PierianDx Patents

PierianDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150066378-A1 Identifying possible disease-causing genetic variants by machine learning classification Pending 27-Aug-2013

PierianDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PierianDx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PierianDx‘s full profile, request access.

Request a free trial

PierianDx Acquisitions (1)

PierianDx’s most recent deal was a Merger/Acquisition with Tute Genomics. The deal was made on 12-Oct-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tute Genomics 12-Oct-2016 Merger/Acquisition Social/Platform Software
To view PierianDx’s complete acquisitions history, request access »

PierianDx FAQs

  • When was PierianDx founded?

    PierianDx was founded in 2014.

  • Where is PierianDx headquartered?

    PierianDx is headquartered in Creve Coeur, MO.

  • What is the size of PierianDx?

    PierianDx has 324 total employees.

  • What industry is PierianDx in?

    PierianDx’s primary industry is Decision/Risk Analysis.

  • Is PierianDx a private or public company?

    PierianDx is a Private company.

  • What is PierianDx’s current revenue?

    The current revenue for PierianDx is .

  • How much funding has PierianDx raised over time?

    PierianDx has raised $98.5M.

  • Who are PierianDx’s investors?

    ARUP Laboratories, ATW Partners, Album VC, Bodhi Capital, and Health Catalyst Capital Management are 5 of 15 investors who have invested in PierianDx.

  • Who are PierianDx’s competitors?

    Genalice, InterpretOmics, Fabric Genomics, Genoox, and Gene By Gene are some of the 22 competitors of PierianDx.

  • When was PierianDx acquired?

    PierianDx was acquired on 01-Aug-2022.

  • Who acquired PierianDx?

    PierianDx was acquired by Velsera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »